{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:36:33Z","timestamp":1790940993539,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vaccine.2010.03.074","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T05:11:14Z","timestamp":1271308274000},"page":"3875-3882","source":"Crossref","is-referenced-by-count":21,"title":["Report of the fourth meeting on \u2018Influenza vaccines that induce broad spectrum and long-lasting immune responses\u2019, World Health Organization and Wellcome Trust, London, United Kingdom, 9\u201310 November 2009"],"prefix":"10.1016","volume":"28","author":[{"given":"Iain","family":"Stephenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Pervikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Palkonyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Kieny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.03.074_bib1","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.vaccine.2008.03.006","article-title":"Report of the third meeting on \u2018Influenza vaccines that induce broad spectrum and long-lasting immune responses,\u2019 World Health Organisation, Geneva, Switzerland, 3\u20134 December 2007","volume":"26","author":"Girard","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib2","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.vaccine.2006.03.035","article-title":"Report of the second meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organisation, Geneva, Switzerland, 6\u20137 December 2005","volume":"24","author":"Hampson","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.vaccine.2004.09.004","article-title":"Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organisation, Geneva, Switzerland, 26\u201327 February 2004","volume":"23","author":"Cassetti","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib4","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1016\/j.vaccine.2009.06.034","article-title":"Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza","volume":"27","author":"Collin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.03.074_bib6","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2010.03.074_bib7","unstructured":"Committee for Proprietary Medicinal Products. Note for guidance on Harmonisation of Requirements for influenza vaccines, September 1996; CPMP\/BWP\/214\/96. Circulaire No 96-0661: 1\u201322."},{"key":"10.1016\/j.vaccine.2010.03.074_bib8","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza A\/H3N2 virus induces protective immunity against lethal infection with influenza A\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib10","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.vaccine.2009.05.099","article-title":"Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults","volume":"27","author":"Karron","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.03.074_bib12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"36","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.03.074_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.1830081007","article-title":"Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell","volume":"8","author":"McMichael","year":"1978","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.074_bib14","first-page":"3478","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.03.074_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"NEJM"},{"key":"10.1016\/j.vaccine.2010.03.074_bib16","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.vaccine.2009.01.136","article-title":"Granzyme B: correlates of protection and enhanced CTL response to influenza vaccination in older adults","volume":"27","author":"McElhaney","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib17","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.074_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.clpt.6100402","article-title":"MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?","volume":"82","author":"O\u2019Hagan","year":"2007","journal-title":"Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.074_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1750-2659.2008.00054.x","article-title":"A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses","volume":"2","author":"Baras","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2010.03.074_bib20","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2009.02.004","article-title":"MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination","volume":"27","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib21","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/S0264-410X(03)00456-0","article-title":"Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults","volume":"21","author":"Frey","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0264-410X(98)00185-6","article-title":"Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons","volume":"17","author":"Minutello","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMc0805274","article-title":"Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1","volume":"359","author":"Stephenson","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2010.03.074_bib24","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.03.074_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib28","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.vaccine.2008.03.093","article-title":"Safety of MF59 adjuvant","volume":"26","author":"Schultze","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib29","doi-asserted-by":"crossref","first-page":"e1000049","DOI":"10.1371\/journal.pmed.1000049","article-title":"Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets","volume":"6","author":"Khurana","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2010.03.074_bib30","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1371\/journal.pmed.0050211","article-title":"Effect of universal vaccination on mortality and health care use","volume":"5","author":"Kwong","year":"2008","journal-title":"PLOS Med"},{"issue":"13","key":"10.1016\/j.vaccine.2010.03.074_bib31","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.vaccine.2004.09.025","article-title":"Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children","volume":"23","author":"Piedra","year":"2005","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2010.03.074_bib32","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.vaccine.2007.02.060","article-title":"Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003\u20132004","volume":"25","author":"Halloran","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib33","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/JVI.01899-07","article-title":"Novel approach to the development of effective H5N1 influenza A virus vaccine: use of M2 cytoplasmic tail mutants","volume":"82","author":"Watanabe","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.03.074_bib34","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2009.04.059","article-title":"Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials, WHO, Geneva, 12\u201313 February 2009","volume":"27","author":"Hayden","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.074_bib35","doi-asserted-by":"crossref","first-page":"e5984","DOI":"10.1371\/journal.pone.0005984","article-title":"Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine","volume":"4","author":"Romanova","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.074_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/14760584.7.6.739","article-title":"Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines","volume":"7","author":"Stech","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.074_bib37","doi-asserted-by":"crossref","first-page":"e6032","DOI":"10.1371\/journal.pone.0006032","article-title":"A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets","volume":"4","author":"Ross","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2010.03.074_bib38","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2010.03.074_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.antiviral.2009.09.005","article-title":"Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge","volume":"84","author":"Wen","year":"2009","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.074_bib40","doi-asserted-by":"crossref","first-page":"e7152","DOI":"10.1371\/journal.pone.0007152","article-title":"Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin","volume":"4","author":"Quan","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.074_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jgm.726","article-title":"Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector","volume":"7","author":"Ni","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2010.03.074_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.vaccine.2008.11.011","article-title":"Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge","volume":"27","author":"Haynes","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1586\/erv.09.3","article-title":"Using plant cells as influenza vaccine substrates","volume":"8","author":"Chichester","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2010.03.074_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1467-7652.2006.00187.x","article-title":"An in-built proteinase inhibitor system for the protection of recombinant proteins recovered from transgenic plants","volume":"4","author":"Rivard","year":"2006","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2010.03.074_bib45","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2008.11.108","article-title":"Plant-derived hemagglutinin protects ferrets against challenge infection with the A\/Indonesia\/05\/05 strain of avian influenza","volume":"27","author":"Shoji","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1467-7652.2008.00384.x","article-title":"Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice","volume":"6","author":"D\u2019Aoust","year":"2008","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2010.03.074_bib47","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.0803467","article-title":"Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice","volume":"182","author":"Poon","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.074_bib48","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/517614","article-title":"Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1","volume":"195","author":"Kreijtz","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.074_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/595984","article-title":"Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques","volume":"199","author":"Kreijtz","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.074_bib50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/erv.09.1","article-title":"Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines","volume":"8","author":"Tang","year":"2009","journal-title":"Expert Vaccine Rev"},{"key":"10.1016\/j.vaccine.2010.03.074_bib51","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2009.02.061","article-title":"DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial","volume":"27","author":"Jones","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib52","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/588431","article-title":"Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A\/Vietnam\/1203\/04 (H5N1) influenza virus","volume":"197","author":"Lalor","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.074_bib53","doi-asserted-by":"crossref","first-page":"e2517","DOI":"10.1371\/journal.pone.0002517","article-title":"Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens","volume":"3","author":"Laddy","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2010.03.074_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.03.074_bib55","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1016\/j.vaccine.2008.11.037","article-title":"Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.074_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1750-2659.2008.00040.x","article-title":"Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch","volume":"2","author":"Frolov","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2010.03.074_bib57","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/S0264-410X(03)00381-5","article-title":"Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion","volume":"21","author":"Myc","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2010.03.074_bib58","first-page":"1252","article-title":"Reproducibility of serologic assays for influenza virus A (H5N1)","author":"Stephenson","year":"2009","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:27:31Z","timestamp":1544549251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10004743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":56,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0264410X10004743"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}